1. Home
  2. PHVS vs HCSG Comparison

PHVS vs HCSG Comparison

Compare PHVS & HCSG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • HCSG
  • Stock Information
  • Founded
  • PHVS 2015
  • HCSG 1976
  • Country
  • PHVS Netherlands
  • HCSG United States
  • Employees
  • PHVS N/A
  • HCSG N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • HCSG Assisted Living Services
  • Sector
  • PHVS Health Care
  • HCSG Health Care
  • Exchange
  • PHVS Nasdaq
  • HCSG Nasdaq
  • Market Cap
  • PHVS 862.3M
  • HCSG 838.4M
  • IPO Year
  • PHVS 2021
  • HCSG N/A
  • Fundamental
  • Price
  • PHVS $16.91
  • HCSG $10.67
  • Analyst Decision
  • PHVS Strong Buy
  • HCSG Buy
  • Analyst Count
  • PHVS 5
  • HCSG 4
  • Target Price
  • PHVS $41.60
  • HCSG $14.00
  • AVG Volume (30 Days)
  • PHVS 50.2K
  • HCSG 545.7K
  • Earning Date
  • PHVS 05-07-2025
  • HCSG 04-23-2025
  • Dividend Yield
  • PHVS N/A
  • HCSG N/A
  • EPS Growth
  • PHVS N/A
  • HCSG 2.57
  • EPS
  • PHVS N/A
  • HCSG 0.53
  • Revenue
  • PHVS N/A
  • HCSG $1,715,682,000.00
  • Revenue This Year
  • PHVS N/A
  • HCSG $6.49
  • Revenue Next Year
  • PHVS N/A
  • HCSG $4.05
  • P/E Ratio
  • PHVS N/A
  • HCSG $20.14
  • Revenue Growth
  • PHVS N/A
  • HCSG 2.65
  • 52 Week Low
  • PHVS $14.14
  • HCSG $9.70
  • 52 Week High
  • PHVS $26.57
  • HCSG $12.99
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 55.23
  • HCSG 46.95
  • Support Level
  • PHVS $14.49
  • HCSG $10.44
  • Resistance Level
  • PHVS $17.00
  • HCSG $11.17
  • Average True Range (ATR)
  • PHVS 1.32
  • HCSG 0.33
  • MACD
  • PHVS 0.18
  • HCSG 0.07
  • Stochastic Oscillator
  • PHVS 71.95
  • HCSG 50.00

About PHVS Pharvaris N.V.

Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.

About HCSG Healthcare Services Group Inc.

Healthcare Services Group Inc is a provider of housekeeping and facility management services to the healthcare industry. The company operates two business segments, both contributing roughly equally to the company's revenue: Housekeeping, laundry, linen, and other services; and Dietary department services. Housekeeping includes management of clients' housekeeping departments, cleaning, disinfecting and sanitizing, laundry, bed linen, and uniform services. Dietary consists of food purchasing, meal preparation, and providing dietitian consulting services. Its clients are nursing homes, retirement complexes, rehabilitation centers, and hospitals in the United States of America.

Share on Social Networks: